M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
S&P maintains "strong buy" after Danish Neurosearch '09 results
11 March 2010 - Standard & Poor's (S&P) downgraded its share price target but reaffirmed its "strong buy" rating on Danish biopharma company Neurosearch A/S (CPH: NEUR) after the latter yesterday posted its financial results for 2009.The company's new target is DKK245, down from the...
If you want to view the full text, you must first purchase archive credits.
Return to Archives
New Search